16/10/2025
As global demand for advanced wound care continues to rise, driven by aging populations, chronic disease, and innovation in biologics, solutions that accelerate healing and reduce complications are more critical than ever.
At Cuprina, we’re proud to be part of this growing MedTech movement. Our clinically proven bio-dressing, MEDIFLY, harnesses the power of Maggot Debridement Therapy (MDT) to disinfect and debride chronic wounds such as diabetic foot and pressure ulcers. Used by leading hospitals in Singapore and Hong Kong, MEDIFLY helps eliminate infection, reduce amputation rates, and promote faster recovery in patients who need it most.
As the wound care market evolves with smart dressings, regenerative solutions, and increasing infrastructure investment, Cuprina remains committed to redefining chronic wound treatment with science-backed innovation.
đź”— Check out the article here: https://industrytoday.co.uk/health_and_safety/wound-care-market-size-2025-2033-biological-skin-substitutes-in-modern-wound-treatment